APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells.

International Journal of Molecular Sciences
Antaripa BhattacharyaDaniela Sarnataro

Abstract

Amyloid precursor protein (APP) is processed along both the nonamyloidogenic pathway preventing amyloid beta peptide (Aβ) production and the amyloidogenic pathway, generating Aβ, whose accumulation characterizes Alzheimer's disease. Items of evidence report that the intracellular trafficking plays a key role in the generation of Aβ and that the 37/67 kDa LR (laminin receptor), acting as a receptor for Aβ, may mediate Aβ-pathogenicity. Moreover, findings indicating interaction between the receptor and the key enzymes involved in the amyloidogenic pathway suggest a strong link between 37/67 kDa LR and APP processing. We show herein that the specific 37/67 kDa LR inhibitor, NSC48478, is able to reversibly affect the maturation of APP in a pH-dependent manner, resulting in the partial accumulation of the immature APP isoforms (unglycosylated/acetylated forms) in the endoplasmic reticulum (ER) and in transferrin-positive recycling endosomes, indicating alteration of the APP intracellular trafficking. These effects reveal NSC48478 inhibitor as a novel small molecule to be tested in disease conditions, mediated by the 37/67 kDa LR and accompanied by inactivation of ERK1/2 (extracellular signal-regulated kinases) signalling and activat...Continue Reading

References

Dec 30, 1992·Biochemical and Biophysical Research Communications·P PåhlssonS L Spitalnik
Apr 15, 1996·Brain Research·G Schrader-Fischer, P A Paganetti
Dec 14, 2001·The Journal of Biological Chemistry·Anja CapellChristian Haass
Jan 1, 2003·Biochemical and Biophysical Research Communications·Richard D BagshawJohn W Callahan
May 9, 2003·The Journal of Biological Chemistry·Stephen H PasternakDon J Mahuran
Dec 29, 2004·International Journal of Pharmaceutics·Qing WangIsmael J Hidalgo
May 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Wendy NobleKaren Duff
Sep 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Olav M AndersenThomas E Willnow
Jan 11, 2007·Journal of Microscopy·S Bolte, F P Cordelières
Jun 9, 2007·The Journal of Biological Chemistry·Vincenza CampanaChiara Zurzolo
Sep 15, 2007·The Journal of Biological Chemistry·Vanessa SchmidtThomas E Willnow
Sep 10, 2010·Journal of Cell Science·Mary Cabell JonasLuigi Puglielli
Nov 23, 2011·The Journal of Cell Biology·Lei WenWen-Cheng Xiong
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Christian HaassSangram Sisodia
Sep 21, 2013·Scientific Reports·Katarina JovanovicStefan F T Weiss
Jul 6, 2014·Scientific Reports·Bianca Da Costa DiasStefan F T Weiss
Dec 22, 2014·Journal of Molecular Biology·Sandra HoefgenManuel E Than
Mar 10, 2015·Expert Opinion on Therapeutic Patents·Katarina JovanovicStefan F T Weiss
Sep 5, 2015·Nature Reviews. Drug Discovery·Yvonne S EiseleJeffery W Kelly
Oct 21, 2015·Journal of Alzheimer's Disease : JAD·Emma C PinnockStefan F T Weiss
Feb 28, 2016·Lancet·Philip ScheltensWiesje Maria Van der Flier
Jul 18, 2017·Advances in Biological Regulation·Miguel A HermidaNick R Leslie
Aug 26, 2017·Progress in Molecular Biology and Translational Science·Daniela SarnataroChiara Zurzolo
Oct 12, 2018·International Journal of Molecular Sciences·Daniela Sarnataro

❮ Previous
Next ❯

Citations

Apr 25, 2020·Journal of Personalized Medicine·Valeria D'Argenio, Daniela Sarnataro
Sep 16, 2020·International Journal of Molecular Sciences·Alejandro R RodaSandra Villegas

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
acetylation
fluorescence microscopy
ELISA
pull-down
phosphatase assay
Assay

Software Mentioned

QikProp

Related Concepts

Related Feeds

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.